Janus Kinase Inhibitors and the Risk of Major Adverse Cardiovascular Events, Thrombosis (Including Fatal Events) and Malignancy
New safety information - Product safety
Read the official notice →- Date
- 2022-10-31
- Country
- Canada
- Product
- CIBINQO (abrocitinib), INREBIC (fedratinib), JAKAVI (ruxolitinib), OLUMIANT (baricitinib), RINVOQ (upadacitinib),…
- Category
- Other
- Source
- Health Canada
Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the brand, model, batch number and pictures against the official notice.
- If yours matches, stop using it and keep it away from children.
- Follow the remedy in the notice: a refund, repair or replacement from the seller or maker. Many recalls also apply to items bought online.
General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.
Other other recalls in Canada
- 2022-11-15
CA
Swift Industries 9’’ black rubber straps recalled due to injury hazard
Injury hazard
Health CanadaOfficial notice →- 2022-11-03
CA
Got Launch Traction Liquid recalled due to lack of appropriate labelling
Labelling and packaging
Health CanadaOfficial notice →- 2022-11-01
CA
- 2022-09-23
CA
Dykstra Greenhouses recalls one lot of Darkest Side of the Moon 2.5g Pre-Rolled Joints Dried Cannabis
Labelling and packaging
Health CanadaOfficial notice →- 2022-09-12
CA
ZOLGENSMA (onasemnogene abeparvovec) and Fatal Cases of Acute Liver Failure
New safety information
Health CanadaOfficial notice →- 2022-08-05
CA
Counterfeit COVID-19 antigen rapid test kits found in Ontario
Product safety
Health CanadaOfficial notice →